Despite decades of efforts to reduce tobacco use, it continues to be the leading cause of preventable disease and death in the United States. To address this public health problem, FDA proposes extending its authority to cover additional products that meet the definition of a tobacco product under the proposed rule: Tobacco Products Deemed To Be Subject to the Food, Drug & Cosmetic Act (Deeming).
Currently FDA regulates cigarettes, cigarette tobacco, roll-your-own tobacco and smokeless tobacco. Proposed newly “deemed” products would include electronic cigarettes, cigars, pipe tobacco, certain dissolvables that are not “smokeless tobacco,” gels, and waterpipe tobacco.
Once the proposed rule becomes final, FDA will be able to use powerful regulatory tools, such as age restrictions and rigorous scientific review of new tobacco products and claims to reduce tobacco-related disease and death.
More Information About the Rule
- Summary of Write-in Campaigns to Deeming Proposed Rule Docket (PDF - 158KB)
- Deeming Issue Snapshot: Regulating Additional Tobacco Products (PDF - 133KB)
- [8/8/14 CLOSED DOCKET] Proposed Rule: Deeming Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic Act (PDF - 658KB)
[6/20/14] Federal Register Notice: Deeming Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic Act; Extension of Comment Period(PDF - 225KB)
- Press Release: FDA proposes to extend its tobacco authority to additional tobacco products, including e-cigarettes
- Regulatory Impact Analysis: Deeming Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic Act